Please wait while the formulary information is being retrieved.
MACRILEN (macimorelin acetate)
- Diagnostic test for growth hormone secretion
0.5 mg/mL oral solution
- 0.5 mg/kg by oral route once after fasting for at least 8 hours
Diagnostic test for growth hormone secretion
- 0.5 mg/kg by oral route once after fasting for at least 8 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Congenital long QT syndrome
- Prolonged QT interval
- Torsades de pointes
Severe
Moderate
- Hypocalcemia
- Hypokalemia
- Hypomagnesemia
MACRILEN (macimorelin acetate)
- Diagnostic test for growth hormone secretion
- Prolonged QT interval
- Dizziness
- Dysgeusia
- Fatigue
- Headache disorder
- Increased appetite
- Nausea
More Frequent
Severe
Less Severe
- Sinus bradycardia
- Diarrhea
- Hyperhidrosis
- Pharyngitis
- Sensation of warmth
- Upper respiratory infection
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Macimorelin
No pediatric safety and efficacy. Indicated as adult diagnostic aid.
- 1 Day – 18 Years
- No pediatric safety and efficacy. Indicated as adult diagnostic aid.
Macimorelin Acetate
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Macimorelin
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool